June 08, 2018
A New Jersey federal judge on Friday dismissed 95 cases from multidistrict litigation accusing Bristol-Myers Squibb and Sanofi-Aventis of falsely marketing the blood thinner Plavix because the patients in those cases never responded to court orders to retain new counsel or represent themselves after their attorneys withdrew.
June 29, 2016
Bristol-Myers Squibb Co. and Sanofi-Aventis U.S. LLC on Wednesday were denied a bid to hold Hawaii to a discovery coordination agreement in multidistrict litigation over allegedly misleading marketing of the blood thinner Plavix, according to New Jersey federal judge's order.
June 13, 2016
Hawaii urged a New Jersey federal court Monday not to hold it to a discovery coordination agreement in multidistrict litigation over allegedly misleading marketing of the blood thinner Plavix, saying Bristol-Meyers Squibb Co. and Sanofi-Aventis U.S. LLC can't force it to abide by a deal made in federal court because the state's claims were remanded.
October 01, 2014
A New Jersey federal judge on Wednesday remanded 57 cases claiming injuries over the blood thinner Plavix despite arguments from Bristol-Meyers Squibb Co. and Sanofi-Aventis U.S. LLC that the suits fraudulently included drug distributor McKesson Corp. and unrelated plaintiffs to dodge federal jurisdiction.